Literature DB >> 35755231

Central Nervous System Involvement of Multiple Myeloma Presenting as Short-lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing: A Case Report.

Victor S Wang1, Ayesha Ahmad2, Santiago Mazuera3, Clinton G Lauritsen2.   

Abstract

Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) are part of the trigeminal autonomic cephalalgia (TAC) group of headache disorders. Attacks present with repeated, severe, sharp, stabbing, or throbbing pain. Patients may experience a single attack, recurrent attacks with pain-free interictal periods, or a sawtooth pattern background pain with superimposed stabs.1,2 Although SUNCT typically presents as a primary headache disorder, it may be secondary to an underlying pathology, such as pituitary tumors or posterior fossa lesions, both intra and extra-axial (vascular lesion, tumor, or bony abnormalities). Multiple Myeloma (MM) with central nervous system involvement (CNS MM) most commonly presents with visual changes (36%), radiculopathy (27%), headache (25%), confusion (21%), dizziness (7%) and seizures (6%).3,4 Secondary SUNCT cases have been sparsely described (less than 60), and CNS MM presenting as SUNCT has not been previously described in the literature.2,5 Our case describes a previously unreported clinical presentation of CNS MM. The report highlights the need for a timely and thorough diagnostic work-up of headache in patients with risk factors for a secondary etiology, which in this case included new-onset, autonomic features, older age, and history of malignancy. A misdiagnosis will preclude a potentially life-extending or saving targeted therapy for the underlying illness. We also aim to remind practitioners of the variability in the clinical symptoms of SUNCT, which are known to occur in a significant number of cases, including migrainous features and dull interictal pain.
© The Author(s) 2022.

Entities:  

Keywords:  SUNCT syndrome; headache; multiple myeloma

Year:  2022        PMID: 35755231      PMCID: PMC9214954          DOI: 10.1177/19418744221086681

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  14 in total

1.  Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.

Authors:  Alessandro Gozzetti; Alfonso Cerase; Flavia Lotti; Davide Rossi; Antonio Palumbo; Maria Teresa Petrucci; Francesca Patriarca; Chiara Nozzoli; Michele Cavo; Massimo Offidani; Michele Floridia; Salvatore Berretta; Roberto Vallone; Pellegrino Musto; Francesco Lauria; Elena Marchini; Alberto Fabbri; Stefania Oliva; Elena Zamagni; Fabiana Gentillini Sapienza; Stelvio Ballanti; Giuseppe Mele; Monica Galli; Maria Teresa Pirrotta; Francesco Di Raimondo
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

2.  Cluster Headache and Other Trigeminal Autonomic Cephalalgias.

Authors:  Stephanie J Nahas
Journal:  Continuum (Minneap Minn)       Date:  2021-06-01

Review 3.  Cluster Headache and Other Trigeminal Autonomic Cephalalgias.

Authors:  Mark Burish
Journal:  Continuum (Minneap Minn)       Date:  2018-08

4.  Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Authors:  Artur Jurczyszyn; Norbert Grzasko; Alessandro Gozzetti; Jacek Czepiel; Alfonso Cerase; Vania Hungria; Edvan Crusoe; Ana Luiza Miranda Silva Dias; Ravi Vij; Mark A Fiala; Jo Caers; Leo Rasche; Ajay K Nooka; Sagar Lonial; David H Vesole; Sandhya Philip; Shane Gangatharan; Agnieszka Druzd-Sitek; Jan Walewski; Alessandro Corso; Federica Cocito; Marie-Christine M Vekemans; Erden Atilla; Meral Beksac; Xavier Leleu; Julio Davila; Ashraf Badros; Ekta Aneja; Niels Abildgaard; Efstathios Kastritis; Dorotea Fantl; Natalia Schutz; Tomas Pika; Aleksandra Butrym; Magdalena Olszewska-Szopa; Lidia Usnarska-Zubkiewicz; Saad Z Usmani; Hareth Nahi; Chor S Chim; Chaim Shustik; Krzysztof Madry; Suzanne Lentzsch; Alina Swiderska; Grzegorz Helbig; Renata Guzicka-Kazimierczak; Nikoletta Lendvai; Anders Waage; Kristian T Andersen; Hirokazu Murakami; Sonja Zweegman; Jorge J Castillo
Journal:  Am J Hematol       Date:  2016-04-24       Impact factor: 10.047

5.  Myelomatous Involvement of the Central Nervous System.

Authors:  Jonas Paludo; Utkarsh Painuly; Shaji Kumar; Wilson I Gonsalves; Vincent Rajkumar; Francis Buadi; Martha Q Lacy; Angela Dispenzieri; Robert A Kyle; Michelle L Mauermann; Arleigh McCurdy; David Dingli; Ronald S Go; Suzanne R Hayman; Nelson Leung; John A Lust; Yi Lin; Morie A Gertz; Prashant Kapoor
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-08-10

6.  Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains.

Authors:  Denise Lee; Anna Kalff; Michael Low; Shane Gangatharan; Prahlad Ho; Ashish Bajel; David Ritchie; Andrew Grigg; Andrew Spencer
Journal:  Br J Haematol       Date:  2013-05-29       Impact factor: 6.998

Review 7.  Extramedullary multiple myeloma with central nervous system and multiorgan involvement: Case report and literature review.

Authors:  Weiyong Lee; Robert Chun Chen; Saravana Kumar Swaminathan; Chi Long Ho
Journal:  J Radiol Case Rep       Date:  2019-12-31

8.  Headache in the elderly: characteristics in a series of 262 patients.

Authors:  M Ruiz; M I Pedraza; C de la Cruz; J Barón; I Muñoz; C Rodríguez; M Celorrio; P Mulero; S Herrero; A L Guerrero
Journal:  Neurologia       Date:  2013-10-17       Impact factor: 3.109

Review 9.  SUNCT and SUNA: An Update.

Authors:  Ashish K Duggal; Debashish Chowdhury
Journal:  Neurol India       Date:  2021 Mar-Apr       Impact factor: 2.117

10.  Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis.

Authors:  Giorgio Lambru; Anker Stubberud; Khadija Rantell; Susie Lagrata; Erling Tronvik; Manjit Singh Matharu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-12-24       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.